OGG1 and rectal cancer: Thus, further investigations, at best in a prospective clinical fashion, are necessary to confirm whether the OGG1 rs1052133 polymorphism is a relevant prognostic biomarker in locally advanced rectal cancer treated in a multimodal fashion.